FdaApplication
NDA 217722
Identifiers
- fda_app_no: NDA217722
Properties
| Property | Value |
|---|---|
| applicant_name | HARM REDUCTION THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2023-07-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIVIVE | NALOXONE HYDROCHLORIDE | 3MG/SPRAY | SPRAY, METERED;NASAL |
1 product